Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vicini

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Clinical Pharmacology and Therapeutics|May 21, 2014
Whither pharmacometrics?: present state and future choicesP Vicini, B P Smith
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1992
Synthesis, hypoglycemic and toxicological evaluation of new 1,2-benzisothiazolyl derivativesP Vicini, L Amoretti, A Caretta
Diabetologia|March 1, 1997
If the minimal model is too minimal, who suffers more: SG or SI?C Cobelli, P Vicini, A Caumo
The American Journal of Physiology|December 31, 1997
The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivityP Vicini, A Caumo, C Cobelli
Diabetologia|August 1, 1996
Is the minimal model too minimal?A Caumo, P Vicini, C Cobelli
IEEE Transactions on Bio-Medical Engineering|February 5, 1999
Glucose effectiveness and insulin sensitivity from the minimal models: consequences of undermodeling assessed by Monte Carlo simulationP Vicini, A Caumo, C Cobelli
Mathematical Biosciences|September 22, 2000
Identifiability and interval identifiability of mammillary and catenary compartmental models with some known rate constantsP Vicini, H Su, J J DiStefano
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|June 1, 1984
Isolation, identification and drug susceptibility of mycobacteria evaluated through radiometric procedures: correlation by conventional methodsP Vicini, G Montini, P G Ramacciotti
Journal of Pharmaceutical Sciences|October 6, 1998
A pharmacokinetic/pharmacodynamic comparison of SAAM II and PC/WinNonlin modeling softwareA C Heatherington, P Vicini, H Golde
CPT: Pharmacometrics & Systems Pharmacology|September 4, 2014
A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 2-model applicationsX Chen, T P Hickling, P Vicini
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Clinical Pharmacology and Therapeutics|May 21, 2014
Whither pharmacometrics?: present state and future choicesP Vicini, B P Smith
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1992
Synthesis, hypoglycemic and toxicological evaluation of new 1,2-benzisothiazolyl derivativesP Vicini, L Amoretti, A Caretta
Diabetologia|March 1, 1997
If the minimal model is too minimal, who suffers more: SG or SI?C Cobelli, P Vicini, A Caumo
The American Journal of Physiology|December 31, 1997
The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivityP Vicini, A Caumo, C Cobelli
Diabetologia|August 1, 1996
Is the minimal model too minimal?A Caumo, P Vicini, C Cobelli
IEEE Transactions on Bio-Medical Engineering|February 5, 1999
Glucose effectiveness and insulin sensitivity from the minimal models: consequences of undermodeling assessed by Monte Carlo simulationP Vicini, A Caumo, C Cobelli
Mathematical Biosciences|September 22, 2000
Identifiability and interval identifiability of mammillary and catenary compartmental models with some known rate constantsP Vicini, H Su, J J DiStefano
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|June 1, 1984
Isolation, identification and drug susceptibility of mycobacteria evaluated through radiometric procedures: correlation by conventional methodsP Vicini, G Montini, P G Ramacciotti
Journal of Pharmaceutical Sciences|October 6, 1998
A pharmacokinetic/pharmacodynamic comparison of SAAM II and PC/WinNonlin modeling softwareA C Heatherington, P Vicini, H Golde
CPT: Pharmacometrics & Systems Pharmacology|September 4, 2014
A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 2-model applicationsX Chen, T P Hickling, P Vicini
Pageof 9